Company

Action Pharma A/S

As of the edition of 20 October 2026, Action Pharma A/S runs 1 drug; it is on route A at 2 targets and on route B at 0 targets.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Stopped1
Total1

Where it needs a new molecule

Route A at 2 targets, route B at 0 targets.

Three of its 2 rows, by target and route
TargetRoute
MC1R Melanocyte-stimulating hormone receptorRoute A
MC3R Melanocortin receptor 3Route A

All 2 rows on route A or B

In the product

2 company-target rows on route A or B; 0 are not shown here, and no score is.

Where its trials are

  • Pregnancy and women's health: 3 trials led
  • Urinary and reproductive: 3 trials led
  • Heart and blood vessels: 1 trials led